PPT-“ Association of OPRM1 and COMT Single Nucleotide Polymorphisms with Hospital Length

Association of OPRM1 and COMT Single Nucleotide Polymorphisms with Hospital Length of Hospital Stay and Treatment of Neonatal Abstinence Syndrome E Wachman M Hayes M Brown J Paul K HarveyWilkes. Mrs. Stewart. Medical Interventions. Central Magnet School. Bell Work. Why is . Taq. polymerase used in PCR instead of human polymerase?. Answer on your own paper . Objective. Use laboratory techniques such as DNA extraction, PCR, and restriction analysis to identify single base pair differences in . Erin L. Keels RN MS NNP-BC. NAS Taskforce Chair. NNP Program . Manager. Nationwide Children’s Hospital . Columbus, Ohio . Disclosures. No conflicts of interest. Off label use of medications for treatment of NAS. How many genes determine important traits?. Where these genes are located?. How do the genes interact? . What is the role of the environment in the phenotype?. Molecular breeding: Gene discovery, characterization, and selection using molecular tools. Ferris State University. Kelly . Geraghty. , Tracy James, Kristen . Lintjer. , . Sara . Potes. , . Rikki. . Zissler. PICO Question. “Are newborn infants with high neonatal abstinence syndrome scores (8 or above) more responsive when nurses treat them with pharmaceutical or non-pharmaceutical interventions?” . Neonatal Abstinence Syndrome & Breastfeeding Special Populations. Caitlin Vanini C-PNP, C-NNP & Stephanie Solpietro C-PNP . NEONATAL ABSTINENCE SYNDROME. OBJECTIVES. UNDERSTAND THE CURRENT STATUS OF MATERNAL OPIOD USE AND NEONATAL ABSTINENCE SYNDROME (NAS) AND ITS’ AFFECT ON COST AND LENGTH OF STAY. How many genes determine important traits?. Where these genes are located?. How do the genes interact? . What is the role of the environment in the phenotype?. Molecular breeding: Gene discovery, characterization, and selection using molecular tools. Opiates and Pregnancy . Opioids in Pregnancy. Opioids are small fat soluble compounds that can easily pass the placental and blood-brain . barrier.. With chronic exposure the fetus develops physical addiction . in NICU. Dr. Darshan Shah. Asst. Professor of Pediatrics. Quillen College of Pediatrics. New Neonatal Abstinence Syndrome. in NICU. Drug use in general population. How Common or Uncommon it is?. Prescribed/Illicit/Not intended . Sean . Loudin. MD. Candice Hamilton, MPH. Disclosures. I have no financial disclosures. Objectives. Understand the mechanism of withdrawal. Discuss the definition of NAS. Understand the local incidence of NAS across the state. Neonatal Abstinence Syndrome Lauritz Meyer, MD September 11, 2015 SDPA Conference Disclosure I have no financial relationships to disclose. Objectives Describe the incidence of Neonatal Abstinence Syndrome in the United States 313029282726252423263022212019302618171615142722r181917f31302928272629253026242523282228292120251918282427232630r172618161115n2726152827t2615b191720Important Phone NumbersAdmitting DepartmentGeneral/P E . Wachman. , M Hayes, M Brown, J Paul, K Harvey-Wilkes, . N . Terrin. , G Huggins, JV . Aranda. , and JM Davis. JAMA Media Briefing. April 30, 2013. Disclosures. No . C. onflicts of Interest. This study was supported in part by NIH funding: DA024806-01A2 to Dr. Marie Hayes and R01DA032889-01A1 to Dr. Jonathan Davis. Introduction. . Suppose that we gathered DNA from a large number of individuals and examined the first 1,000 nucleotides on the first chromosome. . There . would . be some . sections in which the base pair sequence is the same for all of the . Neonatal opioid withdrawal syndrome (NOWS): opioid only withdrawal symptoms . Epidemiology. Incidence of 8.6 per 1000 live births in the U.S in 2016. Incidence of 14 per 1000 live births in NM in 2017.